MAPT and early-onset autosomal dominant Alzheimer disease: In Alzheimer’s disease, overexpression of BCL6 attenuates Aβ-induced neuronal damage and Tau protein hyperphosphorylation, thereby ameliorating neurodegenerative pathology [80].